Company Cryofocus Medtech (Shanghai) Co., Ltd.

6922

CNE100005MV5

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Ratings for Cryofocus Medtech (Shanghai) Co., Ltd.

EPS Revisions

Annual profits - Rate of surprise

Sector Other Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 09:08:10 21/05/2024 BST			5-day change	1st Jan Change
6.97 ^HKD	-1.55%		-10.64%	-62.96%

03-27	Cryofocus Medtech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
01-15	Cryofocus Medtech Gets Marketing Approval in China for Cryoadhesion System	MT

Cryofocus Medtech Shanghai Co Ltd is a China-based medical device company, focusing on the research, development and commercialization of cryotherapy devices. The Company has built a comprehensive product portfolio comprising two core products, approximately 15 other product candidates in various development stages as well as approximately six additional commercialized medical consumables. The two core products comprise the Bladder Cryoablation System and the Endoscopic Clip for Anastomosis. The Company's products mainly target two therapeutic areas: natural orifice transluminal endoscopic surgery, to treat urinary, respiratory, and digestive diseases (such as bladder cancer, COPD, asthma, airway stenosis, gastric cancer, esophageal cancer and others), and vascular interventional therapy to treat cardiovascular diseases (such as atrial fibrillation, hypertension and others).

Number of employees: 392

HKD in Million	2022	Weight	2023	Weight	Delta
Medical Consumables and Devices 100.0 %	32	100.0 %	45	100.0 %	+43.33%

HKD in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	32	100.0 %	45	100.0 %	+43.33%

Managers	Title	Age	Since
Jun Zhu CEO	Chief Executive Officer	50	30/04/19
Jia Wei Li CHM	Chairman	34	31/05/21
Wei Liu DFI	Director of Finance/CFO	34	30/09/20
Ji Hong Qu CTO	Chief Tech/Sci/R&D Officer	60	28/02/22
Kui Wen Zhao CTO	Chief Tech/Sci/R&D Officer	40	31/08/17
Zhi Min Chen PRN	Corporate Officer/Principal	40	30/04/14
Yu Long Liu PRN	Corporate Officer/Principal	47	31/08/18
Thach Buu Duong PRN	Corporate Officer/Principal	55	14/03/13
Yue Peng Diao PRN	Corporate Officer/Principal	39	08/09/13
Hui Xin Liang SEC	Corporate Secretary	-	27/12/21

Members of the board	Title	Age	Since
Hsien-Tse Liang BRD	Director/Board Member	69	01/12/21
Ke Jian Li FOU	Founder	-	14/03/13
Shi Wen Lv BRD	Director/Board Member	55	30/06/14
Jun Zhu CEO	Chief Executive Officer	50	30/04/19
Chun Sheng Zhao BRD	Director/Board Member	52	31/05/21
Da Yong Gao BRD	Director/Board Member	65	01/12/21
Zheng Qin BRD	Director/Board Member	66	01/12/21
Hao Rong Zhu BRD	Director/Board Member	43	31/05/20
Wei Liu DFI	Director of Finance/CFO	34	30/09/20
Jia Wei Li CHM	Chairman	34	31/05/21

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	125,013,402	12,031,010 ( 9.624 %)	0	14.17 %
Stock B	1	114,096,598	21,860,843 ( 19.16 %)	0

Name	Equities	%	Valuation
Hui Li 30.77 %	35,103,176	30.77 %	55 M $
Suzhou Industrial Park Bioventure Investment Management Ltd. 10.77 %	12,283,500	10.77 %	19 M $
Proxima Venture Capital Co. Ltd. 9.043 %	10,317,388	9.043 %	16 M $
Qian Zhang 6.979 %	7,963,128	6.979 %	12 M $
Shi Wen Lv 6.741 %	7,691,600	6.741 %	12 M $
Shengshan Asset Management Shanghai Co. Ltd. 5.322 %	6,072,552	5.322 %	10 M $
Hai Yan Zhang 5.085 %	5,801,688	5.085 %	9 M $
Fullgoal Fund Management Co., Ltd. 4.310 %	4,918,000	4.310 %	8 M $
Jun Zhu 0.9034 %	1,030,697	0.9034 %	2 M $

Name	Equities	%	Valuation
Hui Li 60.84 %	76,060,092	60.84 %	119 M $
Shi Wen Lv 12.25 %	15,308,992	12.25 %	24 M $
Hai Yan Zhang 10.83 %	13,537,272	10.83 %	21 M $
Xiaolu Sun 4.236 %	5,295,368	4.236 %	8 M $

Cryofocus Medtech (Shanghai) Co. Ltd.

Building 15 Lane 3399, Kangxin Road

201321, Shanghai

http://www.cryofocus.com

address Cryofocus Medtech (Shanghai) Co., Ltd.(6922)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

6.461 CNY

Average target price

25.57 CNY

Spread / Average Target

+295.77%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
CRYOFOCUS MEDTECH (SHANGHAI) CO., LTD.	-62.96%	217M
ELI LILLY AND COMPANY	+37.77%	705B
NOVO NORDISK A/S	+32.82%	583B
JOHNSON & JOHNSON	-3.66%	364B
MERCK & CO., INC.	+20.19%	332B
ABBVIE INC.	+4.94%	291B
ASTRAZENECA PLC	+16.64%	238B
ROCHE HOLDING AG	-4.13%	210B
NOVARTIS AG	+10.63%	209B
AMGEN INC.	+8.80%	169B

Other Pharmaceuticals